| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2178722
Max Phase: Preclinical
Molecular Formula: C9H20N5O9P
Molecular Weight: 339.20
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: N.N.O=c1nc(NO)ccn1[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C9H14N3O9P.2H3N/c13-6-4(3-20-22(17,18)19)21-8(7(6)14)12-2-1-5(11-16)10-9(12)15;;/h1-2,4,6-8,13-14,16H,3H2,(H,10,11,15)(H2,17,18,19);2*1H3/t4-,6-,7-,8-;;/m1../s1
Standard InChI Key: AHRZEJCIXABXEB-WFIJOQBCSA-N
Associated Targets(non-human)
Orotidine phosphate decarboxylase 9 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 339.20 | Molecular Weight (Monoisotopic): 339.0468 | AlogP: -2.23 | #Rotatable Bonds: 5 |
| Polar Surface Area: 183.60 | Molecular Species: ACID | HBA: 10 | HBD: 6 |
| #RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 1.23 | CX Basic pKa: | CX LogP: -2.86 | CX LogD: -6.39 |
| Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.25 | Np Likeness Score: 1.29 |
References
| 1. Purohit MK, Poduch E, Wei LW, Crandall IE, To T, Kain KC, Pai EF, Kotra LP.. (2012) Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist., 55 (22): [PMID:22991951] [10.1021/jm301176r] |
Source
Source(1):